Japan, March 3 -- TAKEDA PHARMACEUTICAL CO LTD has got intellectual property rights for 'PLASMA KALLIKREIN INHIBITOR AND USE THEREOF FOR PREVENTING HEREDITARY ANGIOEDEMA ATTACKS.' Other related details are as follows:
Application Number: JP,2023-110592
Category (FI): A61K47/22,C07K16/40,A61P7/10,A61K47/10,A61K47/02,A61K39/395@D,A61K9/08,A61K39/395@N,A61K47/12
Stage: Grant (IP right granted following substantive examination.)
Filing Date: July 5, 2023
Publication Date: Sept. 20, 2023
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication.
